Additional information
White Powder
1105067-93-3
ACI-011219
99.5-101.5°C
C33H33FN2O4
540.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl]-5-hydroxyhept-2-enoic acid sodium salt
(S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl]-5-hydroxyhept-2-enoic acid sodium salt
(2E)-2,3-Dehydroxy Atorvastatin





![LINAGLIPTIN DES-PIPERIDINE AMINE (25 mg) (7-(2-Butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-3,7-dihydro-1H-purine-2,6-dione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)